Interventional pulmonology is a subspecialty of pulmonology that involves the use of minimally invasive procedures to diagnose and treat lung and airway diseases. These procedures can include bronchoscopy, endobronchial ultrasound, and electromagnetic navigation bronchoscopy.
Worldwide revenue from the interventional pulmonology market stands at US$ 1.2 Bn in 2022, with the global market estimated to surge ahead at a CAGR of 4.2% to reach a valuation of US$ 1.9 Bn by the end of 2033.
| Interventional Pulmonology Market Size (2022) | US$ 1.2 Bn |
| Projected Market Value (2033) | US$ 1.9 Bn |
| Global Market Growth Rate (2023-2033) | 4.2% CAGR |
| Market Share of Top 4 Countries | 44.5% |
Request For Free Sample Report of “Interventional Pulmonology Market”@ https://www.persistencemarketresearch.com/samples/12544
The global interventional pulmonology market is expected to grow at a significant rate in the coming years. This growth can be attributed to factors such as the increasing prevalence of lung diseases, the growing geriatric population, and the increasing adoption of minimally invasive procedures.
One of the major drivers of the interventional pulmonology market is the increasing prevalence of lung diseases such as chronic obstructive pulmonary disease (COPD), lung cancer, and asthma. These diseases are becoming more common due to factors such as smoking, air pollution, and exposure to occupational hazards. As a result, the demand for interventional pulmonology procedures is expected to increase.
Companies
- Medtronic Plc
- Boston Scientific Corporation
- Olympus Corporation
- FUJIFILM Corporation
- Becton, Dickinson and Company
- Smith’s Group Plc
- Cook Medical
- Vygon
- Clarus Medical LLC
- Huger Medical Instrument Co. Ltd
- Taewoong Medical Co. Ltd.
Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/12544
Another factor driving the market is the growing geriatric population. As the population ages, the incidence of lung diseases such as COPD and lung cancer is expected to increase. This, in turn, is likely to drive the demand for interventional pulmonology procedures.
The increasing adoption of minimally invasive procedures is also expected to drive the market. Interventional pulmonology procedures are less invasive than traditional surgical procedures and can often be performed on an outpatient basis. As a result, these procedures are becoming more popular among patients and healthcare providers alike.
However, the market also faces certain challenges. One major challenge is the high cost of interventional pulmonology procedures. Additionally, there is a lack of skilled professionals trained in these procedures, which can make it difficult for patients to access these treatments.
Despite these challenges, the global interventional pulmonology market is expected to grow at a significant rate in the coming years. This growth is likely to be driven by factors such as the increasing prevalence of lung diseases, the growing geriatric population, and the increasing adoption of minimally invasive procedures.
In conclusion, the global interventional pulmonology market is poised for significant growth in the coming years driven by increasing prevalence of lung diseases, growing geriatric population, and increasing adoption of minimally invasive procedures. However, the market faces certain challenges such as the high cost of interventional pulmonology procedures and lack of skilled professionals trained in these procedures.
Request Customization @ https://www.persistencemarketresearch.com/request-customization/12544
Key Segments Covered in Interventional Pulmonology Industry Research
Product:
- Bronchoscopes
- Fiberoptic (flexible) Bronchoscope
- Rigid bronchoscope
- Endobronchial Ultrasound Bronchoscope (EBUS)
- Convex EBUS
- Radial EBUS
- Respiratory Endotherapy Devices
- Aspiration Needles
- Biopsy Forceps
- Other
- ENB Systems
- Pleuroscopes
- Semi flexible Pleuroscopes
- Rigid Pleuroscopes
- Airway Stents
- Bronchial Thermoplasty Systems
- Pleural Catheters
- Endobronchial Valves
Indication:
- Lung Cancer
- Asthma
- COPD
- Foreign Body Extraction
- Tracheal and Bronchial Stenosis
- Others
End User:
- Hospitals
- Pulmonology Clinics
- Ambulatory Surgical Centers
- Diagnostic Centers
For More Premium Insights, Check out the Link:
DNA and RNA Sample Preparation market
Single-Use Bioprocess Systems market
Macular Degeneration Treatment market
Polycystic Ovary Syndrome (PCOS) Treatment market
Molecular Diagnostics in Infectious Disease Testing market
Hypercholesterolemia Treatment market
Acquired Orphan Blood Disease market
Bladder Cancer Treatment Drugs market
About Us
Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
Contact Us:
Persistence Market Research
Japan
Persistence Market Research
1-2-1 Kinshi Arca Central Building 14/F Tokyo, 130-0013 Japan
Call 0800-222-1088
United States
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com